Filing Flows › Coya Therapeutics (COYA) › Recalls, complaints & regulation
Coya Therapeutics (COYA): clinical trials
Coya Therapeutics (COYA) beyond its filings: 1 active clinical trial.
Coya Therapeutics' latest quarter
Coya Therapeutics, Q2 2026: revenue $244K (+49% year over year), net loss $6.6M, operating cash flow −$7.4M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Coya Therapeutics have?
1 active study on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.